Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs USFD✓SelectedUSD · USFDGSK vs USFD performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs USFD

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+109.4%
USFD return
+354.6%
Excess return
-245.2%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioUSFDExcessAlpha
1D-0.1%-0.2%+0.2%0.0%
7D-1.3%-1.6%+0.3%-1.1%
30D+2.7%+6.1%-3.4%+1.9%
3M+2.7%-0.7%+3.4%+2.7%
6M+3.3%+31.3%-28.0%-0.2%
YTD+6.5%+43.6%-37.2%+1.5%
1Y+10.7%+50.8%-40.1%+4.8%
3Y+64.4%+155.4%-91.1%+45.2%
5Y+46.7%+213.7%-167.0%+24.8%
10Y+109.4%+350.8%-241.4%+61.1%
All+109.4%+354.6%-245.2%+61.1%

Cumulative growth

Daily Returns

Daily percentage return beside USFD.

Daily Out/Under-Performance

Portfolio return minus USFD return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × USFD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded USFD wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling